Welcome to our blog! -- the place to be to learn about growing up with pediatric brain injury and a wonderful little girl named Sarah, as told by Sarah's Mom!
RSS
Showing posts with label H1N1. Show all posts
Showing posts with label H1N1. Show all posts

The "Pink Piggy" Van and H1N1

Yesterday afternoon, I was fortunate (to my surprise) to be able to get at our pediatrician's office swine flu shots for Sarah, Josh, and Emma. No-o-o!, the office wasn't mobile, and it sure didn't look anything like this van. Not that the humor of the moment would have trumped my children's outrage, even if it had. After all, I was culpable. I had suffered them to be vaccinated point blank. I was unforgiven for so long as it took to drive home and their little arms ached.

To be sure, whether or not to vaccinate for H1N1 at all, as well as what steps to take to care for one's child if s/he does get the flu, continues to weigh on parents' minds across the country. In addition to frequent hand washing to prevent the transmission of germs, many of us have also adopted instant hand sanitizers. I know that I, for one, carry them around in my purse, in the car, and packed in with kid gear to have on hand for those moments when we can't wash up. So far so good. Surfing the Web, though, my attention was drawn to an article about the dangers of their improper use.

Yes, under ordinary circumstances, instant sanitizers safely and effectively destroy the majority of bacteria and viruses that can cause illnesses. They are, however, potently toxic chemicals that can cause unintended injury. The most familiar danger is hand sanitizer poisoning, especially in the very young. Most sanitizers contain 60 percent to 90 percent alcohol (commonly ethyl or isopropyl alcohol) -- a stronger concentration than most hard liquors! If ingested, even a small amount could lead to dizziness, slurred speech, headaches, and even brain damage or death in extreme cases. That translates into being certain to keep them out of sight when not in use, and out of the hands of inquiring little people who might be attracted by their scents or packaging (like my three "peeps") . . . fer shur!



(double click the video to see a larger version play on YouTube.com)

Photo Credit: See Ellen's post, entitled "Update On The Swine Flu" at To The Max featuring the "Pink Piggy van." 0 comments

We're B-A-A-A-C-K!

Well, we're back! Me and our whole household after an unexpected -- and basically uneventful, thankfully! -- bout with an unknown, seasonal malaise that caused headaches and fitful sleep, along with low grade aches and pains. Somehow we managed still to navigate getting flu shots, although not the H1N1, because it is not yet available at our pediatrician's office. Our county public health department has also run into a shortage for distribution. While many parents have anguished over whether or not to get the H1N1 vaccination for their children, based on news stories that the vaccine may not have been adequately tested for safety, here's my take on it:

For myself and my husband, we still feel uneasy -- just because the media has worn us out so -- but plan to go ahead and vaccinate Sarah, her brother Josh, and baby Emma. We trust the findings of the US National Institute of Allergy and Infectious Diseases (NIAID) that has been conducting a series of trials in children age 6 mos-17 years. Here's how the results have broken down:

Preliminary analysis of blood samples from trial participants showed that a single 15-microgram dose of a non-adjuvanted 2009 H1N1 influenza vaccine – the same dose that is in the seasonal flu vaccine – generates an early (within 10 days) immune response that is expected to be protective against 2009 H1N1 influenza virus. (An "adjuvant" is a substance added to a vaccine to boost the immune response to the vaccine if a boost might be needed.)

Generally, the early responses of younger children were less strong. Among those aged 3 to 9 years old, a strong immune response was seen in 36 percent. In the youngest group, between 6 months to 35 months old, a single 15-microgram dose of vaccine produced a strong immune response in 25 percent. NIAID researchers expect that these immune responses will be similar to those for the regular, seasonal flu vaccination and will continue to rise for several weeks following after getting vaccinated. NIAID's study is being closely monitored by the trial physicians and staff, as well as by an independent safety monitoring committee.

For further information about NIAID-sponsored clinical trials of 2009 H1N1 influenza vaccines, see the following NIAID documents: Overview: Pediatric Trials; and Trials in Pregnant Women.
0 comments